Cargando…
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
Radiotherapy (RT) is a highly effective anti-cancer therapy delivered to around 50–60% of patients. It is part of therapy for around 40% of cancer patients who are cured of their disease. Until recently, the focus of this anti-tumour efficacy has been on the direct tumour cytotoxicity and RT-induced...
Autores principales: | Colton, Madyson, Cheadle, Eleanor J., Honeychurch, Jamie, Illidge, Tim M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640712/ https://www.ncbi.nlm.nih.gov/pubmed/33148287 http://dx.doi.org/10.1186/s13014-020-01678-1 |
Ejemplares similares
-
Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response
por: Cheng, Shuhui, et al.
Publicado: (2020) -
Radiotherapy–Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery?
por: Romano, Erminia, et al.
Publicado: (2021) -
Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies
por: Fagnano, Ester, et al.
Publicado: (2023) -
Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1
por: Mukherjee, Debayan, et al.
Publicado: (2023) -
Akt inhibition improves long‐term tumour control following radiotherapy by altering the microenvironment
por: Searle, Emma J, et al.
Publicado: (2017)